A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design.
Rheault MN, Amaral S, Bock M, Chambers ET, Chavers B, Ters ME, Garro R, Gbadegesin R, Govil A, Harshman L, Amer H, Hooper DK, Israni AK, Riad S, Sageshima J, Shapiro R, Seifert M, Smith J, Sung R, Thomas CP, Wang Q, Verghese PS.
Rheault MN, et al. Among authors: amer h.
Front Nephrol. 2023 May 15;3:1181076. doi: 10.3389/fneph.2023.1181076. eCollection 2023.
Front Nephrol. 2023.
PMID: 37675355
Free PMC article.